Trials / Terminated
TerminatedNCT02277613
A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
A Phase 2 Prospective, Randomized, Double-blind, Sham-controlled, Parallel-group, Multi-center Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Healios K.K. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a double-blind, sham-controlled clinical study to evaluate the safety and feasibility of AMI MultiStem therapy in subjects who have had a heart attack (Non-ST elevation MI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AMI MultiStem cells | AMI MultiStem cells administration in coronary artery with a micro-infusion catheter. |
| OTHER | Sham | Sham procedure using Micro-Infusion Catheter in coronary artery without injection. |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2019-06-01
- Completion
- 2020-01-01
- First posted
- 2014-10-29
- Last updated
- 2021-07-22
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02277613. Inclusion in this directory is not an endorsement.